Vitamin B1 and Children's Eye Health: Cross-Eyes, Nystagmus, and the Thiamine-Deficient Brainstem

What Parents Notice First: Cross-Eyes, Jerky Eye Movements, and the Soundless Cry
Why Thiamine Failure Hits the Eye Muscles First
The Clinical Triad: Neurological, Cardiac, and Aphonic Forms
The 2003 Israeli Remedia Outbreak — The Defining Case
Endemic Infantile Beriberi in Southeast Asia
At-Risk Groups Today (Beyond the Obvious)
Diagnosis: The Lab Pattern and the MRI Signature
Treatment: When Hours Matter
Long-Term Outcomes Even After Apparent Recovery
The Dextrose Paradox (Critical for Hospital Care)
Prevention and What to Tell Your Family Doctor
Key Research Papers
Connections

What Parents Notice First: Cross-Eyes, Jerky Eye Movements, and the Soundless Cry

Imagine bringing your three-month-old to the pediatrician and saying, "Her eyes have been crossing." The doctor reassures you that intermittent eye crossing is common in infants and usually resolves on its own. You go home. A week later, the baby seems listless. She is not eating well. And then you notice something that stops your breath: when she cries, no sound comes out.

This combination — a baby whose eyes are turning inward, whose gaze drifts and flickers, who cries in silence — is a medical emergency. It is one of the clearest pictures in all of pediatric medicine that the brainstem is failing from a lack of vitamin B1, also called thiamine.

The inward turning of the eyes that parents notice is called esotropia or, more specifically, abducens palsy. The sixth cranial nerve, the abducens nerve, controls the muscle that pulls the eye outward. When it stops working, the eye drifts inward, producing the cross-eyed appearance. Because both eyes are often affected, the baby may look directly crossed or may switch back and forth, depending on which nerve is weaker on a given day.

The jerky, rhythmic oscillation of the eyes — as if they are following something flickering — is called nystagmus. A parent might describe it as the baby's eyes "shaking" or "dancing." Both abducens palsy and nystagmus arise from the same root cause: the tiny brainstem nuclei that coordinate eye movements are starving for energy, and thiamine is the fuel they need to make that energy.

The silent cry is the most haunting sign. The laryngeal nerve, which animates the vocal cords, is also controlled by the brainstem, and it fails in the same cascade. A baby who has no voice but is clearly distressed — whose mouth is open, whose face is crying, but who makes no sound — has a vocal cord palsy pattern that should prompt immediate evaluation for B1 deficiency. This sign is sometimes called the aphonic form of infantile beriberi, and it is among the most specific findings in clinical medicine for this diagnosis.

What makes this so easy to miss is how gradual the onset can be. The family sees a baby who is "a little off" and "not eating great" before they ever see a cross-eyed infant. Early on, the baby may simply be irritable and restless. Weeks before the eye signs appear, the infant may be vomiting, losing weight, and losing the developmental milestones she had just achieved. By the time the eyes are visibly crossing, the brainstem has been under metabolic stress for some time. This is why understanding the biology matters — it helps families and doctors recognize the warning signs before the most dramatic signs appear.

Why Thiamine Failure Hits the Eye Muscles First

To understand why B1 deficiency produces cross-eyes before almost anything else, you need to understand what thiamine actually does inside a cell.

Thiamine is converted in the body to thiamine pyrophosphate (TPP), which serves as a critical cofactor — a helper molecule — for two of the most important enzymes in energy metabolism: pyruvate dehydrogenase and alpha-ketoglutarate dehydrogenase. Think of these enzymes as the gates that allow glucose, the body's primary fuel, to enter the deep energy production pathway inside the mitochondria. Without TPP, those gates are stuck shut. Glucose gets partially burned, producing pyruvate that cannot go further, which then gets converted to lactic acid — the same burn you feel in your muscles when you sprint. A third enzyme, transketolase, is also TPP-dependent; it is part of the pentose phosphate pathway, which produces the raw materials for making DNA and protecting cells against oxidative damage.

So when thiamine runs low, three things happen simultaneously: less energy is produced from glucose, lactic acid builds up in the tissues, and cells become more vulnerable to oxidative stress. Every cell in the body is affected to some degree — but not equally.

The brainstem nuclei that control eye movement are among the most metabolically active cells in the nervous system. The abducens nucleus — the cluster of neurons in the lower brainstem that drives the sixth cranial nerve — fires constantly, even during sleep, to maintain coordinated gaze. It needs enormous amounts of ATP (the body's energy currency) to keep up this firing rate. When TPP drops, these high-energy cells run out of fuel first, like a sports car that runs out of gas before a hybrid under the same driving conditions.

This is why the eye signs come first. The brainstem neurons that control eye movement are not being singled out by some mysterious mechanism — they are simply the most demanding consumers of the energy that thiamine makes possible. They hit empty before the heart, before the limb muscles, before the speech centers. The eye is the window to the thiamine-deficient brainstem.

A useful analogy: imagine the body's energy supply is a river feeding many farms. When there is a drought, the farms that use the most water — the biggest, thirstiest crops — are the first to wither. The abducens nucleus is that thirsty crop. The rest of the brainstem follows. This is why, if you see the eye signs, you must assume the rest of the brainstem is already in trouble, even if it is not yet showing obvious symptoms.

This also explains the nystagmus. Smooth, stable gaze requires a constant, precisely calibrated signal from several brainstem centers working in concert — the abducens nucleus, the oculomotor nucleus, and the vestibular nuclei. When TPP drops and energy becomes unreliable, this coordination breaks down. The result is the flickering, unstable eye movement that parents describe as their baby's eyes "shaking."

The Clinical Triad: Neurological, Cardiac, and Aphonic Forms

Infantile thiamine deficiency does not always look the same. Doctors who work in areas where it is endemic — or who have seen the Remedia outbreak cases — recognize three overlapping patterns that can occur alone or together.

The Neurological Form

This is what most of this article focuses on. The neurological form includes nystagmus, abducens palsy (cross-eyes), progressive encephalopathy (confusion, lethargy, loss of responsiveness), and seizures. In older infants and toddlers, a clinical picture that resembles Wernicke's encephalopathy in adults can emerge — characterized by the classic triad of eye movement abnormalities, ataxia (unsteady or absent ability to hold the head up or sit), and altered consciousness. Seizures in a nutritionally compromised infant with eye movement abnormalities and lactic acidosis should prompt thiamine administration before lab results return.

The Cardiac Form

The heart is a muscle, and it too depends on pyruvate dehydrogenase to efficiently convert glucose into energy. In the cardiac form of infantile beriberi, the heart fails in a distinctive way: it becomes overactive trying to compensate, producing high-output cardiac failure. The baby's heart is racing, the liver is enlarged (hepatomegaly) because blood is backing up from the failing circulation, and the blood is flooded with lactic acid (lactic acidosis) because every cell in the body is now in the same energy crisis that hit the brainstem first.

A parent might notice a baby who is breathing rapidly, sweating even in a cool room, looking pale or grayish, and not feeding well. This can be mistaken for a respiratory infection or congenital heart disease. The key distinguishing feature is the metabolic context: lactic acidosis, and response to thiamine within hours.

The Aphonic Form (Soundless Cry)

The aphonic form deserves special emphasis because it is the most diagnostically specific sign. A baby who cries silently — whose laryngeal muscles have stopped working because the cranial nerve that controls them has failed — has a clinical picture that is highly specific for thiamine deficiency. There are other causes of vocal cord paralysis in infants, but when it occurs in a breastfed baby who is failing to thrive, whose mother has a diet restricted in thiamine, or who is eating a formula that may be nutritionally incomplete, B1 deficiency must be ruled out immediately.

Families sometimes describe this as a "weak cry" that gets quieter and quieter over days. It is easy to attribute to a cold or congestion. The recognition that the voice is going away, not simply being muffled, is the critical perceptual shift. A completely soundless cry in an infant who is clearly distressed is a neurological emergency.

The 2003 Israeli Remedia Outbreak — The Defining Case

In October 2003, a three-month-old baby was admitted to Tel Aviv Sourasky Medical Center in Israel with an unusual presentation: cross-eyes, nystagmus, a silent cry, and encephalopathy. The pediatric neurologist who examined her, Dr. Aviva Fattal-Valevski, was puzzled. This looked like Wernicke's encephalopathy — a condition caused by thiamine deficiency that is classically associated with alcoholism in adults. But this was an infant. Infants in Israel do not get Wernicke's encephalopathy.

The team drew a blood thiamine level. It was undetectable. They gave IV thiamine. Within hours, the nystagmus began to improve. Within days, the baby began to respond. The eye crossing slowly improved. But the index case was just the beginning.

Dr. Fattal-Valevski began to ask: what had this baby been fed? The answer was Remedia Super Soya 1, a soy-based infant formula manufactured in Israel by the Remedia company. The formula had been specially designed for infants with cow's milk protein intolerance. But due to an error at the vitamin supplier, the batches produced between July and November 2003 had been manufactured without thiamine.

Over the following weeks, as the public health investigation unfolded, approximately 20 infants who had been fed the deficient formula were identified. Two of them died. Most of the survivors had been in the neurological form of the illness, with varying degrees of eye movement abnormality, encephalopathy, and lethargic feeding.

The Israeli Ministry of Health issued an immediate recall. Parents were told to stop using all Remedia soy formula immediately. The national attention to a single puzzling index case at Sourasky Medical Center had, within weeks, unraveled an iatrogenic outbreak affecting dozens of Israeli families.

But the story did not end with the acute illness. Dr. Fattal-Valevski followed the affected children as they grew. At ages 5 to 7 — years after they had recovered from the acute beriberi episode — the children showed persistent and measurable deficits. In a 2009 follow-up study of the cohort, children who had been fed the deficient formula had significantly worse scores in receptive and expressive language, gross and fine motor function, and executive function compared with healthy control children. This was true even in children who had never had overt, clinically diagnosed beriberi — who had simply been fed the deficient formula during the window without developing the full acute presentation.

This finding is perhaps the most sobering lesson of the Remedia outbreak: subclinical thiamine deficiency during the critical window of early infant brain development can leave a permanent footprint on language, movement, and thinking — even when the infant appeared to recover fully, even when no one knew anything was wrong at the time.

Endemic Infantile Beriberi in Southeast Asia

The Remedia outbreak was a manufactured crisis in a high-income country with universal access to formula labeling and regulatory oversight. But infantile beriberi is not a historical curiosity or a manufacturing aberration. It is happening right now, every year, in Cambodia, Laos, Myanmar, and parts of Vietnam and Thailand — and in many of those cases, it is not being diagnosed.

The mechanism in Southeast Asia is different but the outcome is the same: infants being fed by breastfeeding mothers who are themselves severely deficient in thiamine. The deficiency in the mother typically arises from a diet built almost entirely around polished white rice, which has had its thiamine-containing bran layer milled away. Without diverse protein sources, fortified foods, or supplementation, a breastfeeding woman on a white-rice diet may be consuming a fraction of the thiamine she needs — and the breast milk she produces will be correspondingly low in thiamine.

The infant gets a double deficiency: the milk itself is low in thiamine, and the infant's own liver stores are minimal at birth. Unlike fat-soluble vitamins such as A and D, which accumulate in tissue over months, thiamine is water-soluble and turns over rapidly. An infant has perhaps two to three weeks of thiamine stores at birth. When the mother's milk is deficient, those stores are depleted within weeks, and the neurological cascade begins.

The research group that has most rigorously documented this crisis is led by Dr. Kyly Whitfield and colleagues, whose PLOS Neglected Tropical Diseases work in the Cambodian mother-infant cohort demonstrated that subclinical thiamine deficiency in breastfed infants is common and correlates with developmental markers. Their work also identified fermented fish sauce fortification as a validated, culturally acceptable, population-level intervention. Fish sauce is used in cooking throughout the region, including by pregnant and nursing women. Fortifying this conduit with thiamine was shown to substantially raise maternal thiamine levels and, consequently, infant thiamine status through breast milk.

The lesson from Southeast Asia for parents and clinicians in other settings is about hidden dietary restriction. A mother does not have to be eating white rice in Cambodia to be thiamine-deficient. Any severe dietary restriction during pregnancy or breastfeeding — whether from extreme weight-loss dieting, an eating disorder, hyperemesis gravidarum (severe pregnancy vomiting), a vegan diet that lacks fortified foods, or chronic illness with poor appetite — can produce a mother whose breast milk is inadequate in thiamine, and a breastfed infant who silently depetes their stores in the first weeks of life.

At-Risk Groups Today (Beyond the Obvious)

When most doctors think about thiamine deficiency in the modern world, they think about adult alcoholism. But in pediatric practice, the at-risk landscape is much broader — and most of it is invisible in routine screening.

Breastfed Infants of Thiamine-Deficient Mothers

As described above, any mother with a severely restricted diet can produce thiamine-deficient breast milk. The groups at particular risk include: women in the first trimester with hyperemesis gravidarum who are hospitalised with IV fluids but no thiamine supplementation; mothers in eating disorder recovery who are consuming enough calories but not enough micronutrient variety; vegan and vegetarian mothers who rely heavily on refined grains without fortification; mothers on dialysis (dialysis strips water-soluble vitamins at every session); and mothers in food-insecure households who are eating primarily starchy, low-thiamine staples.

Children with ARFID on the Autism Spectrum

Avoidant/Restrictive Food Intake Disorder (ARFID) is a pattern of severely limited food intake — often tied to sensory sensitivities — that is significantly more common in autistic children and adolescents than in the neurotypical population. A child with ARFID may eat only a handful of white-flour foods: white bread, plain pasta, plain rice, plain crackers, and chicken nuggets. This diet is almost entirely composed of refined carbohydrates — foods that deliver glucose load while providing minimal thiamine. Worse, a high-carbohydrate diet actually increases thiamine requirements, because every glucose molecule that enters the energy pathway consumes a thiamine molecule as a cofactor.

Case reports of Wernicke's encephalopathy in autistic adolescents with ARFID have appeared in the medical literature and are almost certainly undercounting the actual incidence. The eye movement abnormalities, confusion, and ataxia that develop in these children are often initially attributed to a new psychiatric episode or to a change in the underlying autism presentation — delaying the lifesaving diagnosis of thiamine deficiency.

Post-Bariatric Adolescents and Young Adults

Bariatric surgery is increasingly performed in adolescents with severe obesity. The stomach-bypass anatomy markedly reduces the absorptive surface area for thiamine (and other water-soluble vitamins), and the postoperative period of very restricted intake dramatically reduces dietary thiamine intake. Without meticulous supplementation, Wernicke's encephalopathy can develop within weeks of surgery in a teenager who was neurologically normal before the procedure.

Total Parenteral Nutrition Without Adequate B1

Children receiving nutrition entirely through IV solutions — because they cannot absorb food through the gut — are entirely dependent on what is put in the bag. Commercially prepared TPN solutions historically did not always include thiamine, or included amounts inadequate for the metabolic demands of a critically ill child. Iatrogenic Wernicke's encephalopathy from TPN without thiamine is well-documented in the pediatric intensive care literature. Current guidelines require explicit thiamine supplementation in TPN, but shortages, substitutions, and prescription errors still occur.

Chronic Emesis and Cyclic Vomiting

Children with cyclic vomiting syndrome have episodes of intractable vomiting lasting days at a time, recurring multiple times per year. During each episode, they cannot absorb oral thiamine. Between episodes, catch-up nutrition often focuses on calories without attention to micronutrient status. Over months to years of recurrent vomiting episodes, thiamine stores can become chronically depleted. Wernicke's encephalopathy in a child with cyclic vomiting syndrome is a known complication that is frequently diagnosed only in retrospect.

Diagnosis: The Lab Pattern and the MRI Signature

If you or your child's doctor is considering thiamine deficiency, here is what the diagnostic workup looks like — and why you should not wait for all the results to come back before starting treatment.

Blood Tests

The most reliable functional test of thiamine status is the whole-blood thiamine pyrophosphate (TPP) level, measured by HPLC (high-performance liquid chromatography). This measures the active form of thiamine in red blood cells and correlates well with clinical status. A level below 70 nmol/L is generally considered deficient, though labs vary in their reference ranges.

The classic biochemical assay, still used in research settings, is the erythrocyte transketolase activation coefficient (ETKA). Transketolase is one of the TPP-dependent enzymes. In this test, blood is drawn and transketolase activity is measured before and after adding excess TPP to the sample. If activity increases by more than 15-25% after adding TPP, the enzyme was previously starved of its cofactor — strong evidence of thiamine deficiency. This test takes longer to run than a direct thiamine level and is not universally available, but it provides functional evidence that cells were actively limited by B1 shortage.

Because pyruvate dehydrogenase depends on TPP to convert pyruvate to acetyl-CoA, thiamine deficiency produces a characteristic metabolic signature on routine labs: elevated blood lactate, elevated pyruvate, and a rising lactate-to-pyruvate ratio. A blood gas showing lactic acidosis in an infant with neurological symptoms is a powerful clue. Pyruvate can be measured separately, but the key signal is the ratio: when lactate is rising faster than pyruvate, the pyruvate dehydrogenase step is the bottleneck — and thiamine is the most treatable cause of that specific bottleneck.

The MRI Signature

Brain MRI in thiamine-deficient infants shows a remarkably characteristic pattern that has been documented extensively since the Remedia outbreak. In the Kornreich et al. 2005 study from AJNR, which imaged the Remedia cohort, the findings were consistent across affected children:

Periaqueductal grey — the narrow channel of brain matter surrounding the cerebral aqueduct (the fluid channel connecting the third and fourth ventricles). This region houses many of the nuclei responsible for eye movement and autonomic regulation, and it is highly metabolically active. On MRI, it lights up as a bright T2/FLAIR signal — the imaging equivalent of inflammation and energy failure.
Mammillary bodies — two small round structures at the base of the brain, critical for memory encoding. Their involvement is why thiamine deficiency in adults causes the permanent memory disorder called Korsakoff syndrome.
Medial thalami — the thalamus relays virtually all sensory and motor signals to the cortex; the medial portions are most vulnerable to thiamine deficiency.
Floor of the third ventricle — this region includes the hypothalamus, which governs feeding, temperature regulation, and hormonal control.

What makes this MRI pattern so useful clinically is its symmetry and its location. Bilateral, symmetric signal changes in the periaqueductal grey and mammillary bodies in a child with altered mental status and eye movement abnormalities is a pattern that practically makes the diagnosis on imaging alone. Other causes of brain injury — stroke, encephalitis, metabolic disorders — produce asymmetric or differently located changes. When an emergency MRI shows this specific pattern, thiamine administration should begin immediately if it has not already.

Importantly, the MRI may be normal in early or mild thiamine deficiency — the metabolic crisis has to be severe enough to produce the tissue changes visible on MRI. A normal MRI does not rule out the diagnosis in a patient with the right clinical picture. Treat first, image second.

Treatment: When Hours Matter

One of the most important things a parent — or a clinician — can understand about thiamine deficiency in infants and children is that the treatment is simple, cheap, essentially risk-free, and rapidly effective. The tragedy in every case of delayed diagnosis is not just that the child suffered — it is that the reversal was sitting in a vial on the pharmacy shelf the whole time.

The Treatment Protocol

For a child suspected of acute thiamine encephalopathy in an ICU setting, the standard protocol is intravenous thiamine. Pediatric doses vary by institution and by severity, but typical ICU protocols use 100-200 mg every 8 hours for the first 24-48 hours, followed by daily dosing until the patient is stable and oral intake is established. For suspected Wernicke's in adults (which has more published guidance), the standard is 200-500 mg IV three times daily for at least 2-3 days.

The therapeutic response timeline is one of the most gratifying in medicine:

Nystagmus begins to resolve within hours of the first IV dose in many patients. A mother who has watched her infant's eyes flicker for days may notice that they have calmed within a few hours of treatment — this is not wishful thinking, it is the biology of brainstem cells rapidly responding to restored energy supply.
Abducens palsy (cross-eyes) begins to resolve within days, though full resolution may take weeks depending on how long the nerve has been injured.
Encephalopathy — the confusion, lethargy, and altered responsiveness — improves over days to weeks. In infants with severe presentations, the response may be slower than the eye signs.
Cardiac failure reverses rapidly with thiamine, often within 24-48 hours, because the heart muscle quickly returns to efficient energy production once the pyruvate dehydrogenase gate is re-opened.

The Cardinal Rule: Do Not Wait

The most dangerous thing a clinician can do is say, "Let's wait for the thiamine level to come back before treating." Whole-blood TPP levels can take 24-72 hours to return from the reference laboratory. During that time, the injury to brainstem neurons continues, and the longer-term neurodevelopmental risk — that quiet footprint on language and memory that the Remedia cohort study documented — deepens.

Thiamine is not toxic at the doses used for treating deficiency. The risk of treating an infant who turns out not to be thiamine-deficient is essentially zero. The risk of not treating an infant who is deficient is permanent neurological injury. This is a one-sided risk equation. Every hour of delay in Wernicke's encephalopathy correlates, in the adult literature, with a worse long-term Korsakoff residue — the chronic memory disorder that follows inadequately treated Wernicke's. The same principle applies to infants. Treat now, confirm later.

Long-Term Outcomes Even After Apparent Recovery

The hardest conversation in thiamine deficiency is the one about what happens to children who survive. Many families are told, after the acute phase resolves, that their child has "recovered." The cross-eyes have improved. The nystagmus is gone. The baby is alert and feeding. Go home.

But the Remedia cohort study, published by Fattal-Valevski et al. in 2009 in Developmental Medicine and Child Neurology, tells a more complicated story — and families deserve to know it.

When the Remedia children were evaluated at ages 5 to 7, the investigators administered a battery of standardized neuropsychological tests. Compared with age-matched healthy Israeli children, the Remedia cohort scored significantly lower on:

Receptive language — understanding what others say, following instructions, vocabulary comprehension
Expressive language — producing speech, naming, sentence structure, fluency
Gross motor function — running, jumping, balance, coordination
Fine motor function — handwriting, drawing, manipulation of small objects
Executive function — planning, working memory, the ability to start and stop tasks flexibly

These are not subtle statistical differences. They are measurable, functional deficits in the skills that children need for school, for friendships, for independence. The language deficits in particular are the ones most likely to go unrecognized until a child hits kindergarten and teachers notice they are not keeping up.

What makes this especially important is the finding regarding children who had no overt beriberi during the deficient formula window — children whose families did not know anything was wrong, who were never hospitalized, whose eyes never crossed. These children still showed developmental differences at age 5-7. The developing brainstem does not need to have a clinical crisis to be injured. It needs only to have been deprived of thiamine during a critical window when it was building the circuits for language, movement, and executive control.

For parents whose children had thiamine deficiency as infants — whether from the Remedia formula, from breastfeeding by a deficient mother, or from any other cause — this means that developmental surveillance needs to be long-term. Speech and language therapy, occupational therapy, and neuropsychological testing in school years are not optional add-ons. They are the evidence-based response to what is known about thiamine's role in early brain development.

The Dextrose Paradox (Critical for Hospital Care)

Here is a scenario that is not hypothetical. A malnourished child is brought to the emergency room unconscious. The ER team moves quickly: they start an IV and hang a bag of dextrose (sugar) solution to prevent hypoglycemia and provide energy. The child does not improve. Over the next several hours, the neurological status deteriorates. An MRI is eventually ordered. The periaqueductal grey is bright. Mammillary bodies are bright. The pattern is unmistakable. The child had subclinical thiamine deficiency, and the IV dextrose precipitated a full Wernicke's encephalopathy crisis.

This scenario has been documented in the medical literature repeatedly, and it is the reason that thiamine administration before IV glucose has become a clinical teaching principle for malnourished or nutritionally uncertain patients.

The biology is this: glucose metabolism via pyruvate dehydrogenase consumes thiamine pyrophosphate. A patient who is marginally thiamine-depleted — not enough to have symptoms yet, but sitting at the edge — has just enough TPP to keep the brainstem cells running at their baseline firing rate. When you flood the system with IV dextrose, you suddenly force all cells to metabolize a large glucose load at once. The demand for TPP spikes. If there is not enough TPP to meet the sudden demand, the pyruvate dehydrogenase step fails, lactate floods the tissues, and the cells most sensitive to energy deprivation — the periaqueductal grey neurons, the abducens nucleus neurons — go into crisis.

The practical rule, now enshrined in guidelines for emergency nutrition support, is:

Any child or adult who has not been able to eat adequately for 5-7 days or more, or who is malnourished, should receive thiamine before or simultaneously with any glucose-containing IV fluids.

For children who are fasted for surgery, this rule generally does not apply — a few hours of perioperative fasting in a well-nourished child does not deplete thiamine. But for children with chronic poor intake — the ARFID child admitted for evaluation, the child with cyclic vomiting admitted for hydration, the child with anorexia admitted for medical stabilization — thiamine supplementation before dextrose is not optional. It costs pennies and takes 15 minutes. Failing to give it can cost a child years of neurological development.

This is one of the most actionable pieces of information in this entire article for families navigating hospital care. If your child is admitted for any reason involving poor nutrition, prolonged vomiting, or restricted intake, it is entirely appropriate to ask the medical team: "Has thiamine been given before the IV fluids?" You are not being difficult. You are asking the right question.

Prevention and What to Tell Your Family Doctor

Prevention of infantile thiamine deficiency is, in principle, straightforward. In practice, it requires intentionality at multiple levels — the individual family, the clinician, and the public health system.

Food Fortification

In the United States, Canada, Australia, and most of Western Europe, staple foods including white flour, bread, breakfast cereals, and rice are mandatorily enriched with thiamine as part of B-vitamin fortification programs. These programs, instituted after the discovery of beriberi's cause in the early twentieth century, dramatically reduced the incidence of thiamine deficiency in populations eating a standard Western diet.

The risk arises when people depart from these fortified staples — when they eat primarily unfortified foods (certain organic or artisan products, imported rice, or the minimally processed packaged foods favored by some children with ARFID). Families who rely heavily on unfortified food systems need to be aware that thiamine is not automatically present in food the way it is in the fortified versions that underpin population thiamine status in high-income countries.

Supplementation in At-Risk Pregnancies

Standard prenatal vitamins in the United States contain approximately 1.4-1.5 mg of thiamine, which meets the recommended dietary intake for pregnant women. However, women with severe hyperemesis gravidarum, eating disorders, or extreme dietary restriction may not absorb oral supplements reliably. Clinicians managing these patients should consider IV or IM thiamine supplementation and should explicitly counsel patients that their infant's neurological development depends on adequate maternal thiamine during the third trimester and lactation.

Breastfeeding recommendations in this context should also be explicit: a mother who has had severe hyperemesis, who is vegan without fortified foods, or who has a very restricted diet should be told directly: "Your B1 level can affect your baby's brain development. Here is how we check it." Maternal thiamine status is not routinely screened in obstetric care. Advocacy for targeted screening in at-risk populations is warranted.

A Script for Your Pediatrician

If your child has an unusual combination of eye movement abnormalities, irritability, poor feeding, developmental regression, or a silent cry, and the standard workup has not found an explanation, it is reasonable to say to your pediatrician or neurologist:

"I've read about thiamine deficiency causing eye movement problems and encephalopathy in infants and children. My child's symptoms seem to fit. Can we check a whole-blood thiamine pyrophosphate level and get a lactate and pyruvate? And if you're considering IV thiamine empirically, I understand it's essentially non-toxic, and I'd rather start it while we're waiting for results."

This is a reasonable, evidence-based request. You are not asking the doctor to guess blindly — you are asking them to test a hypothesis that has biological plausibility, a cheap safe treatment, and catastrophic consequences if missed. In most cases, a good clinician will respond positively to this kind of informed advocacy. If they dismiss it without engaging with the reasoning, consider requesting a referral to pediatric neurology or a metabolic disease specialist.

Key Research Papers

Fattal-Valevski A, Kesler A, Sela BA, et al. Outbreak of life-threatening thiamine deficiency in infants in Israel caused by a defective soy-based formula. Pediatrics 2005;115(2):e233-e238. PMID 15687431
Kornreich L, Bron-Harlev E, Hoffmann C, et al. Thiamine deficiency in infants: MR findings in the brain. AJNR Am J Neuroradiol 2005;26(7):1668-74. PMID 16148620
Fattal-Valevski A, Bloch-Mimouni A, Kivity S, et al. Epilepsy in children with infantile thiamine deficiency. Dev Med Child Neurol 2009. doi:10.1111/j.1469-8749.2008.03161.x
Smith TJ, Johnson CR, Koshy R, et al. Thiamine deficiency disorders: a clinical perspective. Nutrition Bulletin 2021. PMC7986856
Whitfield KC, Bourassa MW, Adamolekun B, et al. Thiamine deficiency disorders: diagnosis, prevalence, and a roadmap for global control. PLOS Neglected Tropical Diseases. PMC5600402
Biousse V, Newman NJ. Neuro-ophthalmic manifestations of Wernicke encephalopathy. Curr Opin Ophthalmol 2020. PMC7335288
Bhatt K, Bhatt C, Siddiqui S, et al. Wernicke encephalopathy in pediatric avoidant/restrictive food intake disorder (ARFID). Pediatrics 2023. PMID 37632134
Sechi G, Serra A. Wernicke's encephalopathy: new clinical settings and recent advances in diagnosis and management. Lancet Neurol 2007;6(5):442-55. PMID 17434099
Isenberg-Grzesiak J, Rau NS, Bhatt K, et al. A systematic review of pediatric Wernicke encephalopathy. Pediatric Neurology 2023. PMID 36801573
Whitfield KC, Karakochuk CD, Liu Y, et al. Poor thiamine and riboflavin status is common among women of childbearing age in rural and urban Cambodia. J Nutr 2015;145(3):628-33. PMID 25733459
Maresova P, Kuca K, Kuban P, et al. Thiamine deficiency and associated clinical disorders. Frontiers in Neuroscience 2023. PMC10476936

Live PubMed Searches

Connections

Back to Table of Contents